Screener
National Health Investors NHI Debt Instrument Face Amount
Debt Instrument Face Amount at other companies
Other financials
Where this comes from
Reported directly by National Health Investors in its filing.
Tagged under the XBRL concept us-gaap:LineOfCredit.
The source filing: National Health Investors’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000877860-26-000199
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Revolving credit facility - unsecured | $438,000 | $204,000 |
| Bank term loan - unsecured | — | 125,000 |
| 2031 Senior Notes - unsecured, net of discount of $1,474 and $1,635, respectively | 398,526 | 398,365 |
| 2033 Senior Notes - unsecured, net of discount of $3,447 and $3,707, respectively | 346,553 | 346,293 |
| Private placement note - unsecured | 100,000 | 100,000 |
| Unamortized debt issuance costs | (8,557) | (9,844) |
| Total debt, net | $1,274,522 | $1,163,814 |
Item 1. Financial Statements
FAQ
- What is National Health Investors's debt instrument face amount?
- National Health Investors (NHI) reported debt instrument face amount of $438M in Q2 2026.
- How has National Health Investors's debt instrument face amount changed year-over-year?
- National Health Investors's debt instrument face amount increased by 15.9% year-over-year, from $378M to $438M.
- What does debt instrument face amount mean?
- The face value or principal amount of debt instruments.
Ask your AI about National Health Investors's debt instrument face amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude